Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
IFCT-0802 CPC : Essai de phase 2-3 randomisé comparant l’efficacité des chimiothérapies de type PCDE (cisplatine, cyclophosphamide, épidoxorubicine, étoposide) ou PE (cisplatine, étoposide), associées ou non à du bévacizumab, chez des patients ayant un cancer bronchique à petites cellules. [essai clos aux inclusions] https://www.kusajili.fr:443/Trial/2FRRvbLAMEWovRx40l6lUw%24ifct-0802-cpc-essai-de-phase-2-3-randomise-comparant-lefficacite-des-chimiotherapies-de-type-pcde-cisplatine-cyclophosphamide-e
I have read and accept the terms of use of the site and the Privacy Policy
Send your message